Early Stage Her2 Breast Cancer The Atempt Trial

A detailed review of the

The results of the

Sara M. Tolaney, MD, MPH, instructor of medicine, Harvard Medical School, attending physician of medical oncology, ...

Tiffany Traina, MD, reviews clinical

Panelists discuss their neoadjuvant and adjuvant treatment approaches for

HER2

Paolo Tarantino, MD, Dana-Farber

Dr Javier Cortes discusses results from the randomised, open-label,

Harold J. Burstein, MD, PhD, senior physician, associate professor of medicine, Harvard Medical School, Dana-Farber

Ian Krop, MD, summarizes key clinical

An overview of the APHINITY

Sara M. Tolaney, MD, MPH, discusses the

Update for

... of the

Comprehensive insight on adjuvant regimens used to manage

Angela M. DeMichele, MD, professor of Medicine and Epidemiology, University of Pennsylvania, discusses results of a the ...

Denise A. Yardley, MD, considers the diagnostic and prognostic workup of a 56-year-old woman who presents with

Experts consider how the KATHERINE

Sara M. Tolaney, MD, MPH, describes the rationale for preoperative therapy in patients with

KOLs in